Farrell Michael J. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Farrell Michael J. has filed 5 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $24.39M.

Profile

Farrell Michael J.

Michael J. Farrell is the Chief Executive Officer and Chairman of ResMed Inc., a leading global company in respiratory care devices. He has played a significant role in the company's growth and innovation in the treatment of sleep apnea and other respiratory conditions.

RoleChairman and CEO, Director
Notability50/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-09RMDRESMED INCS — Open-market sale5.0K$218.55$1.09M
2026-07-09RMDRESMED INCM — Option exercise5.0K$146.34$730K
2026-06-09RMDRESMED INCS — Open-market sale5.0K$193.96$968K
2026-06-09RMDRESMED INCM — Option exercise5.0K$146.34$730K
2026-05-11RMDRESMED INCS — Open-market sale5.0K$207.82$1.04M
2026-05-11RMDRESMED INCM — Option exercise5.0K$146.34$730K
2026-04-09RMDRESMED INCS — Open-market sale [10b5-1]5.0K$225.50$1.13M
2026-04-09RMDRESMED INCM — Option exercise [10b5-1]5.0K$146.34$730K
2026-03-11RMDRESMED INCS — Open-market sale [10b5-1]5.0K$251.03$1.25M
2026-03-11RMDRESMED INCM — Option exercise [10b5-1]5.0K$146.34$730K
2026-02-10RMDRESMED INCS — Open-market sale [10b5-1]5.0K$273.78$1.37M
2026-02-10RMDRESMED INCM — Option exercise [10b5-1]5.0K$146.34$730K
2026-01-08RMDRESMED INCS — Open-market sale [10b5-1]5.0K$248.46$1.24M
2026-01-08RMDRESMED INCM — Option exercise [10b5-1]5.0K$146.34$730K
2025-10-07RMDRESMED INCS — Open-market sale8.0K$282.85$2.27M
2025-10-07RMDRESMED INCM — Option exercise8.0K$101.64$814K
2025-09-08RMDRESMED INCS — Open-market sale8.0K$278.14$2.23M
2025-09-08RMDRESMED INCM — Option exercise8.0K$101.64$814K
2025-08-15RMDRESMED INCA — Grant or award12.3K$0.00
2025-08-07RMDRESMED INCS — Open-market sale8.0K$279.48$2.24M

Companies — Last 90 Days

Frequently Asked Questions

Who is Farrell Michael J.?

Michael J. Farrell is the Chief Executive Officer and Chairman of ResMed Inc., a leading global company in respiratory care devices. He has played a significant role in the company's growth and innovation in the treatment of sleep apnea and other respiratory conditions.…

How many SEC Form 4 filings has Farrell Michael J. submitted recently?

5 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Farrell Michael J. been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 14 open-market sales ($24.39M) across all tracked filings.

Where can I see all of Farrell Michael J.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Farrell Michael J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.